Results 51 - 75 from 137 for "antibiotice"
-
Antibiotice Iasi Extends CEO's Mandate For Four Years
05.20.2020
-
Antibiotice Iasi Approves RON20M Dividends: 5.6% Yield
04.09.2020
-
Antibiotice Iasi Sales Up Driven By 30% Higher Demand Compared With Previous Months
03.30.2020
Antibiotice Iasi, the largest pharmaceutical producer in Romania, has seen sales up lately, as demand for medicines increased 30%, company CEO Ioan Nani says. more
-
Antibiotice Iasi Net Profit Declines 10% in 2019, to RON30.8M
02.27.2020
State-owned Antibiotice Iasi (ATB.RO), one of the leading local pharmaceutical manufacturers, said Thursday its net profit declined 10% in 2019, to RON30.8 million, while sales revenue grew 6.8%, to more
-
Antibiotice Iasi Plans to Double Exports and Revenue Starting 2020
12.18.2019
Antibiotice Iasi (ATB.RO), one of the leading local pharmaceutical manufacturers, plans to double exports abroad soon, which would double its revenue. more
-
Antibiotice Iasi Posts RON242M Sales, RON21.5M Net Profit In Jan-Sept 2019
11.15.2019
Romanian state-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) on Friday said it ended the first nine months of 2019 with sales revenue of RON242 million, comparable with the result reported more
-
Antibiotice Iasi Plans To Register Over 25 Products In Vietnam
10.08.2019
Antibiotice Iasi, one of the leading players in the local pharmaceuticals industry and the main producer of the active substance nystatin globally, plans to register in Vietnam over 25 products in more
-
Antibiotice CEO Ioan Nani Plans to Double Salaries at His Company in Five Years
09.24.2019
The ambition of Ioan Nani, CEO of pharmaceutical producer Antibiotice Iasi and one of the longest-standing executives in local pharmaceutical industry is too boost sales and profitability over the more
-
Antibiotice Iasi To Start Payment Of RON6.7M Dividends As Of Sept 20
09.06.2019
-
Antibiotice Iasi Posts Higher Sales, Profit in 1H/2019
08.08.2019
Romanian state-owned pharmaceutical producer Antibiotice Iasi (ATB.RO) on Thursday reported total sales of RON172.3 million in the first half of the year, up 9%, and a net profit of RON22.3 million, more
-
Antibiotice Iasi to Double Production of Creams and Ointments by 2020
11.28.2018
Pharmaceutical producer Antibiotice Iasi’s investment in its new topical product (such as creams, lotions and ointments) plant will amount to EUR20 million and will be completed by the end of next more
-
Antibiotice Iasi 9-Month Sales Up 3% On Year To RON241M
11.14.2018
-
Antibiotice Iasi To Pay Out RON17.8M Worth Of Dividends, At 5% Yield
04.26.2018
-
Antibiotice To Open Offices In Kiev And Chisinau
02.26.2018
Pharmaceutical company Antibiotice (ATB.RO) reached its targets last year and will continue development by consolidating presence on international markets this year, says CEO Ioan Nani. more
-
Antibiotice Iasi Sales Revenue Up 3%, Net Profit Up 14% In First 9 Months Of 2017
11.15.2017
-
Antibiotice Iasi GM: Romania Has Europe's Lowest Drug Prices And World's Highest Clawback Tax
09.13.2017
-
Antibiotice Iasi Posts Higher Profit, Of RON19.19M, In 1H/2017
08.17.2017
-
Antibiotice Iasi 1Q Profit Down 26% To RON5.3M, Turnover Up 1% To RON55.4M
05.15.2017
-
Antibiotice Iasi To Pay Dividends At A 4% Yield From 2016 Profit
03.06.2017
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will pay dividends of RON0.023/share from 2016 profit, at a 4.1% yield, the company said in a statement to Bucharest Stock Exchange Monday. more
-
Antibiotice Iasi To Boost Production Of Creams, Ointments And Gels
01.20.2017
A number of 60 million drug packs leave the plant of pharmaceutical producer Antibiotice Iasi annually, 35% to 40% of which topical products (creams, ointments, gels), says chief executive Ioan Nani, more
-
SIF Oltenia Buys 780,000 Shares In Antibiotice Iasi For RON395,000
12.15.2016
-
Antibiotice Iasi Ceases Payment Of 2012 Dividends As Of November
10.17.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will cease the payment of dividends from 2012 profit as of November 1, 2016, the company said in a statement Monday. more
-
Ioan Nani, Antibiotice Iasi: Clawback Tax Became A Drawback For Drugmakers
10.02.2016
The medicine industry is more and more affected by the clawback tax, as the tax currently accounts for approximately 30% of the value added of a drugmaker, which will soon lead to the collapse of drug more
-
Antibiotice Iasi Sales Up 9% In January-June
08.01.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) reported sales of RON143.8 million in January-June 2016, up 9% from the year-earlier period. more
-
Antibiotice Iasi Seeks RON30M Loan From UniCredit Bank
07.11.2016
Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) has called a shareholders' meeting for August 11 to approve the contracting of a RON30 million (EUR6.7 million) loan from a UniCredit Bank. more